NCT07683195Enrolling by invitation
Research on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics Prediction
Source: ClinicalTrials.gov · Last updated 7 Jul 2026
Brief summary (registry, in English)
This study aims to develop a model for predicting postoperative recurrence in patients with LAGC using artificial intelligence (AI) technology based on preoperative computed tomography (CT) images
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 900 (estimated)
- First submitted
- 26 Jun 2026
- Start date
- 1 Jan 2020
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Liu Yang
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07683195
What you commit to
- Study type: Observational
- Planned participants: 900
- From 1 Jan 2020 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- preoperative treatment for LAGC (radiotherapy, chemotherapy, or systemic therapy);
Other illness
- previous malignancies;
Other
- unsatisfactory gastric distention or inability to identify the primary tumor;
- image artifacts.
Who the study is looking for
- pathology diagnosis of LAGC (pT2NxM0-pT4NxM0);
- radical gastrectomy with D2 lymph node dissection (\>15 lymph nodes);
- available clinicopathological data;
- patients underwent contrast-enhanced abdominal CT scans within 4 weeks before surgery.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| QianfoshanH Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.